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ABSTRACT 
Oral cancer is both preventable and a curable disease. 
Preventable, because the pre malignant stage can be detected by 
screening and curable because the very early stage can be cured. It is the 
commonest cancer among people. The incidence and mortality from this 
disease in developing countries is very high, because of the 
unavailability of organized screening  programmes. The objective of the 
investigator is to identify the factors of oral cancer, to identify the pre 
malignant changes in oral mucosa among tobacco chewers by toludine 
blue test and to associate the relationship with the demographic 
variables. The investigator interviewed and examined 60 subjects 
through structured questionnaire in English. The toludine blue test to 
identify the pre malignant changes in oral mucosa was found to be 
highly sensitive and can be performed by not only physician but also 
other trained health care providers. Among the 60 people seen by vital 
staining, 50% of them were found positive by chi square test and 
referred to the concerned department for further management. The role 
of a nurse in interacting with the tobacco chewers and the results of the 
study had given ideas that certain factors such as smoking, chewing,  
alcohol use, pan parag, gutkha, hans, plays a vital role in the occurrence 
of pre malignant changes in the oral mucosa. From this study it was 
concluded that some factors associated with the occurrence of the pre 
malignant changes of the oral mucosa and also it is obvious that the low 
cost methods for oral cancer prevention do have a vital role in reducing 
the incidence of oral cancer. 
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CHAPTER  - I    
INTRODUCTION 
 “ I Keep six honest serving men, they taught me all I know. Their 
names are what, why, when, how, where and who” 
-Rudyard kipling 
Cancer is not a single disease with a single cause; rather it is a  
group of distinct diseases with different causes, manifestations,  
treatments, and prognoses. More than two million people are diagnosed 
each year with cancer, affecting one of various body sites. Cancer is a  
leading cause of death next to the cardio vascular disease which is the 
predominant for mortality in India. Although the numbers of cancer 
deaths have decreased slightly, more than 560,000 people were expected 
to die from a malignant process. Cancer can be considered a chronic 
disease requiring ongoing management, rather than a terminal illness. It 
consists of more than 100 different conditions characterised by 
uncontrolled growth and spread of abnormal cells. Normal mechanisms 
of growth and proliferation are disturbed which results in distinctive 
morphologic alterations of the cell and aberrations in tissue patterns. 
The malignant cells is able to invade the surrounding tissue and 
regional lymph nodes. Primary cancer usually  has a predictable natural 
history and pattern of  spread. 
Metastasis is the secondary growth of the primary cancer in 
another organ. The cancer cells migrates through a series of steps to 
another area of the body. Most patients die as a result of metastases 
rather than progression of the primary cancer. Metastasis begins with 
local invasion followed by detachment of cancer cells that disseminate 
via the lymphatics and blood vessels and eventually establish a 
secondary tumour in another area of the body. Lymph nodes are often 
the first site of distant spread.    
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The relative frequency of oral cancer in Asia is higher compared 
to other cancers, but its importance lies in its reported high mortality.  
Infact, approximately 50% of patients with oral cancer will die within 5 
years mainly because of delay in diagnosis. Neverthless, if oral cancer is 
diagnosed during stage I, the survival rate improves to 86%. 
In the oral cavity, there are numerous mucosal disorders 
designated as potentially malignant, whose diagnosis and treatment may 
favour early detection or prevention of cancer thereby diminishing its 
incidence and mortality. 
There is no agreement regarding the efficacy of conventional oral 
examination in the detection of potentially malignant disorders and early 
oral cancers. There are several tests and adjunctive diagnostic   
techniques that are now  commercially positive staining correlated with 
clinico pathologic. Oral health is essential in improving one’s quality of 
life. Any abnormality ranging from dental decay to fatal oral cancer 
affects individuals well being. 
Tobacco usage has become a major health problem. While there 
are many forms of tobacco product, especially tobacco chewing, hans, 
gutka, pan parag. 
Tobacco pyrolysis produces tobacco containing by products and 
free radicals which are carcinogenic. They act by disruption of normal 
cellular and molecular mechanisms Oral cancer may occur on the lips or 
anywhere within  the mouth [eg: tongue, floor of the mouth, buccal 
mucosa, soft palate, hard palate, pharyngeal walls, and tonsils]. Oral 
cancer is the most common cancer in Indian males. It accounts for 50% 
to 70% of total cancer mortality.The incidence is nearly 11% in males 
and 5% in females. It is more common in men (male- to-female ratio of 2:1). 
Mortality rates have been decreasing since the early 1980s. The 5-year 
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survival rate for all stages of cancer of the oral cavity and pharynx 
combined is 53% , and the 10-year rate  is 43%. 
Although the definitive cause of oral cancer is unknown, there are 
a number of predisposing factors. Factors that influence the 
development of oral cancer include tobacco use (e.g. Gutka, tobacco 
chewing, cigar, cigarette, pipe, snuff), excessive alcohol intake, and 
chronic irritation such as from a jagged tooth or poor dental care. 
In the modern world due to the advancement of science and 
technology, the life expectancy of the population has increased. A great 
number of the people are living to older are at risk to chronic diseases , 
cancer is the fearful and dreadful disease for several reasons. 
Cancer , the very  utterance of the word sends down a shiver  to 
our spine. It spells agony despair gloom and death. Cancer is curable 
and there is life after cancer. In the light of present knowledge, early 
detection and prompt treatment of cancer and pre- cancerous conditions 
provide the best possible protection against the cancer for the individual 
and the community. 
Cancer is today not a mysterious killer as was earlier because its 
evolution can be recognized even before it str ikes. The early warning 
signs are often  vague and  common to all other illness. If public learn to 
recognize in the earliest stage and seek doctor’s  advice , they may save 
themselves. [Indian cancer society_2005]. 
Despite of public importance, there is no effective prevention 
programme in  most  developing countries  and the risk of disease  and 
death due to oral cancer remains largely uncontrolled. Invasive  cancer 
is preceded by  a long phase of precancerous lesions that can be detected 
by simple treatment which prevents the invasive cancer. 
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1.1   NEED FOR  THE  STUDY 
Oral health is essential in improving one’s quality of life. Any 
abnormality ranging from dental decay to fatal oral cancer affects 
individual’s well being.  Oral cancer is a significant threat to the public 
health as is often not diagnosed until it is advanced.    
Tobacco usage has become a major health problem. While there 
are many forms of tobacco product, most common is the manufactured 
cigarette, hans, gutka, pan parag. They act by disruption of normal 
cellular and molecular mechanisms. 
Despite advances in detection and treatment of oral cancer, the 
overall survival rate is less than 50%. Oral cancer when detected at an 
early stage is often curable, inexpensive to treat and affords a better 
quality of life.  
Various methods have been developed to supplement clinical 
examination and to improve diagnosis of oral cancer in its early stage. 
The most evaluated adjunct for lesion detection is toludine blue, a 
metachromatic acidophilic dye.  Dysplasia in premalignant lesions 
contains much more DNA and RNA than the normal epithelium due to 
active cellular proliferation. So use of in vivo staining by means of 
toludine blue is based on the fact that it selectively stains acidic tissue 
components such as DNA and RNA.  Oral lesions stained with toludine 
blue showed consistent loss of chromosomal genetic information, termed 
loss of heterozygosity. 
Previous studies showed that sensitivity and specificity of 
toludine blue were quite reliable in revealing early oral premalignant 
lesions and monitoring recurrences of oral cancer.  Toludine blue 
positive staining correlated with clinicopathologic risk factors and high 
risk molecular patterns.  
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A question needs to be answered is whether toludine blue can be 
used to screen premalignant lesions occurring in tobacco chewers. 
Cytological study of oral cells is a non invasive technique that is 
well accepted by the patient, and therefore a better option for early 
diagnosis of potentially malignant lesions in tobacco chewers.1% 
toludine blue is used to detect dysplasia and cytological changes in oral 
smears. 
Many studies with toludine blue used Papanicoloau kit for 
staining smears. Studies  carried out  showed that toludine blue 
enhanced the staining characters of pap stain by improving cytological 
features and stain quality. However little attention has been given  to the 
effect of different staining procedures in toludine blue application. 
Aim of the present study is to assess the smears before and after 
application of toludine blue in tobacco chewers. Toludine blue (also 
known as tolonium chloride) is a vital dye that may stain nucleic acids 
and abnormal tissues. It has been used for decades as an aid to the 
identification of mucosal abnormalities of the cervix as well as in the 
oral cavity. It has been valued by surgeons as a useful way of 
demarcating the extent of a lesion prior to excision. While not currently 
approved by the FDA for us as an oral cancer  screening technique in the 
United States, toludine blue has been championed in other parts of the 
world for several decades as a means of identifying clinically occult 
lesions inpatients whose oral mucosa may otherwise be normal – this, as 
a screening test or adjunct. Various attempts to clinically highlight 
probable dysplastic areas before biopsy  have, unfortunately, not proven 
to be absolutely reliable but may be of some help where there is 
widespread "field change" such as seen in patients at high risk for oro 
pharyngeal squamous cell carcinoma[ OSCC]. Toludine blue (TB) 
staining is a simple and inexpensive diagnostic tool that uses a blue dye 
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to highlight abnormal areas of mucosa. TB is a basic metachromatic 
nuclear stain which stains nuclear material of malignant lesions and 
PML but not normal mucosa, used by (a) the patient rinsing the mouth 
with 1% acetic acid for 20 seconds followed by a similar rinse with 
water twice for 20 seconds; (b) rinsing the mouth with 5-10 cc. 1% 
toludine blue solution; and (c) rinsing with 1% acetic acid solution (5 
oz.) for about 1 minute followed by a water rinse. In the highest risk 
population, prior upper autodigestive tract cancer patients, TB has a 
higher sensitivity to detect carcinoma in situ (CIS) and OSCC when 
compared to a COE (96.7% and 40%, respectively). False positive 
staining (when lesions stain blue, but no carcinoma is identified after a 
biopsy is taken) occurred in 8-10% of cases associated with keratotic  
lesions and the regenerating edges of ulcers and erosions. Here, the 
probability of a false negative finding for invasive OSCC is low and the 
absolute number of false positive tests is expected to be reduced. The 
clinical appearance of a dark royal blue stain may be significantly 
related to the nuclear uptake of TB, compared to pale royal blue staining 
which may be unrelated to any histological feature. Studies assessing 
TB have shown a sensitivity and specificity ranging from 93.5 to 97.8% 
and 73.3 to 92.9%, respectively. TB staining may identify high-risk oral 
PMLs with poor outcome and positive TB staining may be related to 
genetic changes [allelic loss or loss of heterozygozity (LOH)] associated 
with progression to OSCC even in histologically benign lesions and 
lesions with mild dysplasia. TB may also help pre-operatively; in one 
reported case of OSCC, there were malignant or pre-malignant cells 
more than 1 cm away, requiring a resection of a size that would not have 
been addressed during COE alone, though, from the discussion above, it 
can be seen that even mucosa of a normal appearance might be expected 
to contain molecular changes of early carcinogenesis. 
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1.2 STATEMENT OF THE PROBLEM 
A study to identify the Pre-malignant changes in Oral Mucosa 
among Tobacco Chewers by Toludine Blue test in Medical Wards at 
Rajiv Gandhi Government General Hospital , Chennai-03”. 
1.3 OBJECTIVES 
1. To identify the changes in oral mucosa among tobacco chewers. 
2. To assess the oral mucosa after the application of toludine blue 
among tobacco chewers. 
3. To compare the effectiveness of changes in oral mucosa before 
and after the application of toludine blue among tobacco chewers. 
4. To find out the association between the selected demographic 
variables and the effectiveness of toludine blue among tobacco 
chewers. 
1.4 OPERATIONAL DEFINITION 
Identify  
Able to recognize something which can be distinguish from other. 
Premalignant 
A premalignant is a condition occurring before the onset of 
malignancy in more number of patients. 
Oral Mucosa  
Is the mucous membrane epithelium of the mouth. 
Toludine Blue 
Is a dye which stains the mucous membrane. 
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Tobacco Chewers 
Individual  having habit of chewing tobacco. 
1.5 HYPOTHESIS  
H-1 : People have poor knowledge regarding oral cancer and cancer 
prevention programme. 
H-2: There will be a significant association between the selected 
demographic variables and the risk factors. 
1.6  ASSUMPTIONS 
1. Oral cancer is the commonest cancer among south Asians and 
tobacco chewers. 
2. It is assumed that tobacco chewers may have inadequate 
knowledge regarding pre malignant changes. 
3. Early identification and appropriate management will prevent the 
mortality and morbidity due to oral cancer among tobacco 
chewers. 
4. Screening helps the tobacco chewers to detect cancer by simple 
method at an earlier stage. 
5. Health education will bring about positive lifestyle practices 
towards prevention of oral cancer. 
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CHAPTER  -II 
“Literature is the human activity that takes the fullest and most 
precise account of variousness , possibility , complexity and difficulty. 
                                                                    -Lionel Trilling. 
REVIEW OF LITERATURE 
The review of literature is a critical summary of research on a 
topic of interest, often prepared to put a research problem in context    
[polit 2004] 
A literature review is a critical and in- depth evaluation of the 
previous related research . Literature review aids in familiarizing the 
researcher with the existing knowledge base and develop an 
understanding of the conceptual framework , related studies with 
occurrence of oral cancer among the male  and female aged between 18 -
60years. Review of literature thus provides a knowledge base for 
proceeding research. 
2.1 REVIEW OF RELATED STUDIES 
PART 1: Literature related to knowledge and awarenes regarding 
cancer screening 
PART 2:  Literature related to visual inspection of oral 
mucosa using acetic acid and toludine blue.  
PART 1:  Literature Related To Knowledge And Awareness 
Regarding Oral Cancer Screening 
Mishra G. et. al.,(2011) had conducted a study to determine 
cancer awareness among men and women of low socioeconomic status 
in Mumbai slums.Data of consenting participants , collected using 
structured  questonarrie, was differentiated into good and poor level of 
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awareness using point based grading procedure. The study concluded 
that cancer creating awareness about screening, its availability, and 
motivating the general population for screening is necessary. 
Cancer link Trustee Board  (1998) carried out a project in London 
and studied the knowledge and opinions of  men and women regarding 
their awareness about screening services for oral mucosal cancer. 194 men 
and women completed questionnaires and the result showed that they were 
unaware of the screening services. Many others held misconceptions about 
the smear test and fear, embrassment and previous negative experiences all 
inhibited initial or repeat attendance for screening. 
PART II: LITERATURE RELATED TO VISUAL INSPECTION 
OF THE ORAL MUCOSA USING ACETIC ACID AND 
TOLUDINE BLUE 
Rahman F  TIPPU SR et.al.(2012) Department of oral pathology 
and microbiology jaipurThe study included 86 participants suspected of 
having oral premalignant lesions or oral squamous cell carcinoma. One 
percent toludine blue was applied to the lesions, followed by cytology.  
A biopsy was then performed on the tissue. Histopathologically 
proven oralpremalignant lesions/oral squamous cell carcinoma lesions were 
analyzed for sensitivity, specificity, postive predictive value, and 
negative predictive value of both screening techniques. The association 
of screening techniques and histopathologic diagnosis among 
the oral premalignant lesions, oralsquamous cell carcinoma, and benign 
groups were analyzed using the Fisher exact test. P < .05 was considered 
significant 
Toby steele et.al. (2011) The purpose of this study was to evaluate 
the efficacy of the toludine blue (TB) test as a diagnostic tool in the 
detection of malignant and dysplastic lesions of the oral cavity. This 
study was carried out because of a lack of consensus among different 
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authors on the utility of TB, as well as to determine useful adjuncts to 
detect oral pre-cancer and cancer. The study included 160patients with 
oral mucosal disorders that included suspicious or malignant lesions 
detected at clinical visual examination, confirmed by histopathological 
evaluation. 
Upadyay J, Rao NN,(2011) Department of oral pathology,  
Mathura, India  Toludine blue stain is used as a marker to 
differentiate lesions at high risk of progression in order to improve early 
diagnosis of oropharyngeal carcinomas. This study focused on 
45 oral mucosal lesions in 32 patients (13 female, 19 male). In 9 cases, 
multiple biopsies were collected. Of the 45 lesions examined, 26 
(57.0%) were defined clinically benign, while 19 (42.3%) were defined as 
suspected lesions (premalignant or malignant). According to the clinical 
examination, the sensitivity was 53% (16/30) and for toludine blue 
staining 96.2% (26/27) (p = 0.0007). The specificity was 80% (12/15) 
for clinical examination and 77.7% (14/15) for toludine blue staining (p 
= 0.79). In conclusion toludine blue stain has been shown to be a 
reliable aid when clinical examination is unable to 
differentiate lesions at high risk of progression and then it improves 
early diagnosis for oral cavity and oropharyngeal cancer. 
Onofre MA et.al.(2010) The objective of this study was to evaluate 
the reliability of in vivo staining with toludine blue in the detection 
of oral epithelial dysplasia, in situ carcinoma, and invasive squamous cell 
carcinomas in potentially malignant epithelial lesions (PMELs) and 
superficial oral ulcerations suggesting malignancy. 
Fifty patients with PMELs and superficial oral ulcerations suggestive 
of malignancy were selected from those treated at the OralMedicine Service, 
Faculty of Dentistry, Araraquara, Brazil. All lesions were submitted to 
staining with an aqueous solution of 1% toludine blue, followed by biopsy 
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and histologic analysis. The sensitivity, specificity, and positive and 
negative predictive values were calculated. 
Histologic diagnosis revealed that 14% of the lesions analyzed 
were in situ carcinoma and invasive squamous cell carcinomas, 12% 
were epithelial dysplasias, 13% were keratosis, 40% were lichen planus,  
and 8% were other benign lesions. The sensitivity of the staining was 
77%, the specificity 67%, and the positive and negative predictive 
values 43.5% and 88.9%, respectively. 
Staining with toludine blue was demonstrated to be highly reliable 
in the detection of in situ carcinoma and invasive squamous cell 
carcinoma, because false-negative results for the lesions did not 
occur. Toludine blue staining is an adjunct to clinical judgment and not 
a substitute for either judgment or biopsy. 
Vacher C , Legens M, Rueff B, LezyJP (2009) Early diagnosis 
of oral carcinomas allows a limitation of functional consequences of 
surgical treatment. A prospective study was designed in 270 alcoholic 
patients. We practiced a clinical examination of the oral cavity by a 
stomatologist followed by a Toluidin blue test. The clinical examination 
permitted to detect 1 carcinoma and 23 leukoplakias. The 
Toluidin blue test revealed one more carcinoma and two leukoplakias 
more. The early diagnosis of oral carcinomas in alcoholics patients gives 
them a better survival. The Toluidin blue test could be proposed as an 
aid to early diagnosis of these carcinomas. 
Patton L.L et.al (2009) studies that assessed the diagnostic  
accuracy of vital tissue staining with toludine blue , visualisation adjuncts 
(viziLite, Microlux DL, Orascoptic DK, VEL scope), toludine blue staining 
and vizilite (chemoluminescent light detection system ) in combination , 
or cytopathology (Oral CDx brush test system) for the detection of 
premalignant and malignant lesions were eligible for inclusion. Included 
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studies were required to use histological confirmation of tissue biopsy as 
the reference standard and to report sufficient data to calculate measures 
of diagnostic accuracy. In most included studies, patients had suspicious 
oral lesions or a history of oral cancer, but some had known current oral 
cancer. Limited study details and results were reported in an online 
supplement , including details of adjunctive tests used , and in the case of 
visualisation adjuncts, operator details. 
Allegra E , Lombardo N, Puzzo L, Garozzo A(2009) Toludine 
blue stain is used as a marker to differentiate lesions at high risk of 
progression in order to improve early diagnosis of oropharyngeal 
carcinomas. This study focused on 45 oral mucosal lesions in 32 patients 
(13 female, 19 male). In 9 cases, multiple biopsies were collected. Of 
the 45 lesions examined, 26 (57.0%) were defined clinically benign,  
while 19 (42.3%) were defined as suspected lesions (premalignant or 
malignant). According to the clinical examination, the sensitivity was 
53% (16/30) and for toludine blue staining 96.2% (26/27) (p = 0.0007). 
The specificity was 80% (12/15) for clinical examination and 77.7% 
(14/15) for toludine blue staining (p = 0.79). In conclusion toludine blue 
stain has been shown to be a reliable aid when clinical examination is 
unable to differentiate lesions at high risk of progression and then it 
improves early diagnosis for oral cavity and oropharyngeal cancer. 
Fedele S (2009) The World Health Organization has clearly 
identified prevention and early detection as major objectives in the 
control of the oral cancer burden worldwide. At the present time, 
screening of oral cancer and its pre-invasive intra-epithelial stages, as 
well as its early detection, is still largely based on visual examination of 
the mouth. There is strong available evidence to suggest that visual 
inspection of the oral mucosa is effective in reducing mortality 
from oral cancer in individuals exposed to risk factors. Simple visual 
examination, however, is well known to be limited by subjective 
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interpretation and by the potential, albeit rare, occurrence of dysplasia 
and early OSCC within areas of normal-looking oral mucosa. As a 
consequence, adjunctive techniques have been suggested to increase our 
ability to differentiate between benign abnormalities and 
dysplastic/malignant changes as well as to identify areas of dysplasia/ 
early OSCC that are not visible to naked eye. These include the use 
oftoludine blue, brush biopsy, chemiluminescence and tissue 
autofluorescence. The present paper reviews the evidence supporting the 
efficacy of the aforementioned techniques in improving the identification 
of dysplastic/malignant changes of the oral mucosa. We conclude that 
available studies have shown promising results, but strong evidence to 
support the use of oral cancer diagnostic aids is still lacking. Further 
research with clear objectives, well-defined population cohorts, and 
sound methodology is strongly required. 
All lesions were submitted to TB staining. The sensitivity and 
specificity for the detection of malignant or dysplastic lesions by this 
test were65.5% and 73.3%, respectively. Overall, the detection ratewith 
TB (sensitivity) was slightly lower compared withthose reported by 
other authors but the specificity was comparable to several reports. 
Positive predictive value(35.2%) was also lower than previous studies,  
where as negative predictive value (90.6%) was similar. The simplicity 
of the test procedure and the validity of derived values suggest TB 
staining can be a valuable adjunct to the diagnostic process, as long asit 
is carefully correlated with the clinical characteristics of.the mucosal 
disorder and histopathological diagnosis. 
Scully et.al.(2008)  had conducted a study conventional oral 
examination is the standard method of revealing pre malignant lesion 
and oral squamous cell carcinoma, confirming the clinical suspicion by 
biopsy and histopathological examination.Most cancers of the oral 
cavity are oral squamous cell carcinomas [oscc], and tobacco, alcohol 
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and betel use the main factors for these and many potentially malignant 
lesions(PML).The main high risk groups are older adult males and 
females who use tobacco and alcohol. 
Nagaraju, et.al.(2008) has done a study of the 60 cases (30 cases 
of pre malignant and 30 malignant lesions), both the stains were retained 
in 52 cases whereas four cases of malignant lesions of poorly 
differentiated squamous cell carcinoma and one case of moderately 
differentiated squamous cell carcinoma and two cases of premalignant 
lesions(erosive lichen planus) failed to retain both the stains while one 
case failed to retain toludine blue stain of the premalignant lesions,  
15[50%], 12[40%] and three [10%] lesions comprised of homogenous 
leukoplakia, speckled leukoplakia and erosive lichen planus , 
respectively. 
Epstein JB et.al (2007) Toludine blue (TB) has been shown to aid 
in the detection and diagnosis of oropharyngeal squamous cell 
carcinoma (OSCC)and oral premalignantlesions (OPLs). TB has been 
shown to enhance visualization of oral lesions and assist in identifying 
sites of increased risk of dysplastic/malignant change and promote 
biopsy. TB has been shown to identify lesions with molecular changes 
associated with risk of progression of OPLs to OSCC. A recent 
prospective longitudinal study showed TB retention in histologic 
benign lesions and lesions with mild dysplasia that are at increased risk 
of progression to cancer. Clinical tr ials show that TB is useful in 
identifying asymptomatic OSCC and premalignant lesions at risk of 
progressing to SCC, which might otherwise be undetected 
until lesions become more advanced. The data supports TB use 
in oral examination of patients at risk of OSCC. 
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Drimel O et. al. (2007) Improvement of survival rate and quality of 
life after treatment of oral squamous cell carcinoma as well as cost 
reduction requires reliable early diagnosis of the tumor and its 
precursor lesions. Four different screening methods are primarily 
employed: toludine blue staining (visually detectedlesions: sensitivity 70-
100%, specificity 25-67%), photodynamic diagnosis (sensitivity 94-99%, 
specificity 60-89%), autofluorescence (no data published so far) and 
modern oral cytology (sensitivity 80%,specificity 95-100%). Additional 
analytic procedures such automated image analysis, DNA image 
cytometry and immunocytochemistry can be used to enhance the low 
sensitivity of conventional oral cytology. While these methods have 
achieved sensitivity and specificity approaching 100%, the studies 
involved clearly-defined entities such as large oral squamous cell 
carcinomas and aphthae. The modern and methodenhanced oral cytology 
is a simple, value-based and inexpensive tool for early diagnosis 
of oral squamous cell carcinoma and its precursor lesions. Surgical 
biopsy and histopathological examination remains the gold standard for 
definitive diagnosis. 
Gupta A, Singh M(2007) To evaluate the usefulness of toludine blue 
and brush biopsy in precancerous oral lesions and squamous cell 
carcinoma.The study was conducted at Moti Lal Nehru Medical College, 
Allahabad, India. Ninety-six patients with suspicious oral lesions who 
attended the outpatient clinics of otorhinolaryngology were screened with 
in vivo toludine blue staining and oral brush biopsy.Oral brush biopsy 
showed high specificity and sensitivity. Toludine blue staining was highly 
sensitive and moderately specific for malignant lesions but less sensitive 
for premalignant lesions.Early detection of oral carcinoma is possible even at 
the precancerous stages by using noninvasive, painless and outpatient 
procedures, such as in vivo toludine blue staining and brush biopsy. 
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Kerr AR Shah SS(2006) Department of oral and maxillofacial 
pathology USA. This article outlines how to perform a standard 
comprehensive extraoral and intraoral examination and the existing 
commercially available adjunctive techniques for the early detection 
of oral cancer and premalignant lesions. Visualization-based techniques 
(e.g., autofluorescence and chemiluminescence), toludine blue vital 
staining, cytopathologic tests and high-risk human papillomavirus testing 
are discussed in detail, including the indications and protocols for use, 
their advantages and disadvantages and clinical cases Recent advances in 
techniques for detecting oral premalignant lesions and oral squamous 
cell carcinoma have improved the chances of early diagnosis. Adjuncts 
for detection of lesions include toludine blue staining and cytologic 
examination. The primary objective of this study was to assess the 
efficacy of 1% toludine blue (modified Mashberg technique) and 
cytology in detection of oral premalignant lesions and oral squamous 
cell carcinoma 
Silverman SJR(2005) had conducted a study on oral cancer screening 
using visualization techniques. These visual techniques can be divided into 
two general categories. One is the simple visual screening method, such as 
direct visual inspection, during which theoral mucosa is visualized with either 
the naked eye or a low powered magnification device after the application of 
a solution of 1% acetic acid  that is used as a chemical contrast agent to 
highlight regions .The advantages of DVI compared with oral cytology for 
these settings are that it is inexpensive , it does not require a laboratory 
infrastructure, and it provides an immediate result. 
Mashberg A , Samit  (2005) An examination of the oral cavity and 
oropharynx in asymptomatic patients at high risk requires an orderly 
visual inspection of the entire oral and oropharyngeal mucosa with 
particular attention to the tongue, floor of mouth, soft palate, uvula, 
tonsillar pillars, and the lingual aspects of the retromolar trigones. 
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Completion and clear documentation of the entire examination should be 
recorded. Detected lesions that do not resolve in a reasonable length of 
time--two to three weeks--require intense and assiduous investigation. 
The following specifics should be considered. 1. Alcohol drinkers and 
cigarette smokers, especially those 40 years of age and older, are at very 
high risk for the development of upper aerodigestive tract and lung 
squamous carcinomas. 2. The floor of the mouth, the ventrolateral tongue, 
and the soft palate complex are the high-risk sites within the oralcavity 
and oropharynx. 3. Persistent mucosal erythroplasia rather than 
leukoplakia is the earliest visual sign of oral and oropharyngeal 
carcinoma. These lesions should not be regarded merely 
as precancerous changes. The evidence indicates that these lesions in 
high-risk sites should be considered to be invasive carcinoma or 
carcinoma in situ unless proven otherwise by biopsy. 4. Toludine blue 
staining is a useful diagnostic adjunct, particularly as a method of ruling 
out false-negative clinical impressions. It may also be used as a rinse in 
high-risk patients to encompass the entireoral mucosa after a negative 
clinical examination and as a guide to improve biopsy yields. 5. If oral or 
oropharyngeal cancer is identified, evaluations of the larynx, 
hypopharynx, esophagus, and lungs should be performed to rule out 
multiple primary cancers 
Jahanshah salehinjad et.al., (2003) A total of 60 smokers and non-
smokers with an age range of 30-40 , were selected for the study . These 
were patients of the Faculty of Dentistry of the Mashhad University of 
Medical sciences  , for routine dental checkups .The smokers had been 
using a minimum of 20 cigarettes a day for atleast 10 years. Neither the 
smokers nor non-smokers had any oral lesions ,systemic disease or even 
any histopathological dysplasia in microscopic evaluation. The smears 
were taken from clinically normal buccal mucosa.  
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CONCEPTUAL FRAME WORK 
The framework is a brief explanation of the theory or those 
portions of a theory that are to be tested in a quantitative study.  
Conceptual framework presents the logically constructed concepts of the 
research study. Conceptual framework is usually constructed by using 
the researcher’s own experience. 
The conceptual frame work of the study was derived from the 
Roy’s Adaptation Theory” by Sr.Callista Roy. This theory is concerned 
with the focus, target and the nursing care indicated. 
The investigator has concerned the focus as oral mucosa 
assessment, the target as the identification of premalignant changes and 
the indicated nursing care is the application of Toludine Blue test to 
identify the pre malignant changes. 
The assessment of demographic variable of age, gender, education and 
occupation income in assessed and also the medical related variables 
like habit of tobacco chewing, alcohol consumption is also assessed. 
Selection of samples was based in the oral mucosal assessment scale.  
In pre-assessment the inspection of oral mucosa with magnifying 
less in done.  
In this system input, throughput and output is used.  
INPUT: 
Input is identified as stimuli that can come from the environment 
or from within the person and person’s adaptation level. The 
intervention is toludine blue test. The investigatory intervened the 
indicated nursing actions  
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Step 1: 
The first step is, r insing of mouth with 1% acetic acid for 20 
seconds followed by 
Step 2: 
Rinsing of mouth with 1% toludine blue for 30 seconds followed by 
Step 3: 
Rinsing of mouth with 1% acetic acid for 20 seconds 
Throughput 
Through put makes use of an individual’s process and effectors. It 
denotes the post assessment as inspection of oral mucosa by magnifying 
lens after 5 minutes of toludine blue test.  
  Out put 
Output refers to the subject oral mucosa changes. It denotes the 
pre malignant changes  
In the output, the assessment of pre-malignant changes includes  
the following. 
The pre-malignant changes are 
• Normal 
• Inflamed 
• Leukoplakia 
• Erythroplakia 
The investigator identified that there were some pre-malignant 
changes among the tobacco chewers 
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FIGURE 1: CONCEPTUAL FRAME WORK OF MODIFIED ROY’S ADAPTATION MODEL 
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CHAPTER- III 
“Much of the research is a systematic attempt to exploit what is known 
and make it better.” 
-Kevin Kelly. 
RESEARCH METHODOLOGY 
The methodology of research indicates the general pattern of 
organizing the procedure for gathering valid and reliable data for the 
purpose of investigation. This chapter deals with steps used for 
collecting and organizing data. It includes research design, research 
approach, setting, sample and sampling technique, development and plan 
for data analysis. 
The present study is designed to rule out the presence of pre 
malignant changes in oral mucosa among people admitted in Medical 
wards at Rajiv Gandhi Government General Hospital –Chennai-03. 
In this study, research methodology adopted to identify the factors 
associated with the occurrence of pre malignant changes in oral mucosa 
among tobacco chewers male and female aged between 18-60 years 
admitted in medical wards at Rajiv Gandhi Government General 
Hospital –Chennai-03.  
3.1 RESEARCH APPROACH 
The research approach was selected in quantitative approach. The 
study was based on the observation and examination of the staining as a 
tool to assess the person for the early diagnosis and treatment.  
3.2 RESEARCH DESIGN 
The study was a non experimental design  that provided factual 
information about the existing condition. Here the cross sectional 
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Descriptive design was used. This refers to the collection of data 
directly from the subject by structured questionarrie or interview. 
3.3 VARIABLES IN THE STUDY 
Independent Variable:  Visual inspection of the oral mucosa by 
staining. 
Dependent Variable:  Premalignant /malignant changes of oral mucosa. 
3.4 SETTING 
This study was conducted in the medical wards at the Rajiv 
Gandhi Government General Hospital Chennai -03 
3.5 POPULATION 
The study population includes  both male and female  aged 
between 18 -60 years admitted in medical wards at Rajiv Gandhi 
Government General Hospital ,Chennai-3. 
3.6 SAMPLE 
All the subjects chewing tobacco admitted in Medical Wards with 
the age between 18 to 60 years. 
3.7 SAMPLE SIZE 
         The sample size for the study was 60 which comprises of male and 
female admitted in medical wards. 
3.8 SAMPLING TECHNIQUE 
A non probability convenient sampling technique was used to 
select the subject. The subject consists of male and female aged between 
18- 60 years ,who are admitted in medical wards. 
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3.9 CRITERIA FOR SAMPLE SELECTION 
Inclusion Criteria 
• Tobacco chewers with minimum having habit of  tobacco chewing 
for less than 2 years. 
• Males and females aged between 18-60 years. 
• The subjects who are able to understand Tamil and English.  
Exclusion Criteria 
• The subjects who are not willing to participate in the study. 
• Subjects who have cancer and other illness. 
• Subjects with systemic diseases like diabetes, heart and 
neurological diseases .  
3.10 DEVELOPMENT AND DESCRIPTION OF THE TOOL 
The tool used in the study was an interview/observation of oral 
mucosa of tobacco chewers. 
DESCRIPTION OF THE TOOL 
The instrument used for the collection of data was a questionnaire 
for assessing the presence of risk factors of oral cancer. The 
questionnaire was prepared in English and data was collected through 
interview method. It has three sections –SECTION A, B & SECTION C 
Section A: Demographic  Data  
Section B : Factors associated with the causes for pre malignant changes 
in the oral mucosa .  
a) Tobacco chewing 
b) Manner of tobacco usage 
c) Tobacco usage per day 
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d) Smoking 
e) Alcohol consumption  
Section- C: Observation tool for  Visual Inspection of the oral 
mucosa by magnifying lens. 
1. Oral mucosal assessment 
2. Appearance of oral mucosa  
3. Visual inspection of oral mucosa after rinsing with 1% acetic acid ,  
1% toludine blue and again rinsing with 1% acetic acid with 
magnifying lens. 
4. Presence of inflammation 
5. Presence of leukoplakia 
6. Presence of erythroplakia 
7. Presence of fibrosis 
3.11CONTENT VALIDITY 
      The content validity was obtained from the Director, Head of 
the Department, Institute of Internal Medicine, Rajiv Gandhi 
Government General Hospital and Medical Surgical Nursing Experts.  
3.12 PILOT STUDY 
A formal permission was obtained from  The Director, Head of 
the Department ,Institute of Internal Medicine, Rajiv Gandhi 
Government General Hospital, Chennai-03. The pilot study was 
conducted in Medical Wards. 6 subjects  selected by non probability 
convenient sampling technique. The results showed positive for pre 
malignant changes in oral mucosa by Toludine blue test. The study is 
practically feasible. 
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3.13 RELIABILITY 
After pilot study reliability of the tool was assessed by using inter 
observer method and its correlation coefficient r value is 0.88. This 
correlation coefficient is very high and it is good tool to identify the pre 
malignant changes in oral mucosa by toludine blue test  in medical 
wards.  
3.14 DATA COLLECTION PROCEDURE  
The investigator obtained formal written permission from 
Director, Institute of Internal Medicine, Rajiv Gandhi Government 
General Hospital Chennai -03 to conduct the study. The subjects were 
selected by non – probability convenient sampling technique, the 
investigator introduced herself explained the purpose of the study 
ensured confidentiality and informed written consents from the subjects. 
Interview techniques were obtained through information regarding 
demographic data. The study was done by the investigator after getting 
consent from subject based on the visualization of oral mucosa by 
magnifying lens. Total number of samples were 60 and average time is 
40 minutes per subject. Initially the investigator inspect the subjects oral 
mucosa by magnifying lens with check list and intervention is rinsing of 
mouth with 1% acetic acid for 20 seconds followed by rinsing of mouth 
with 1% toludine blue for 30 sec followed by rinsing of mouth with !% 
acetic acid for 20 seconds. After 5 minutes post assessment was done by 
inspection of oral mucosa with magnifying lens based on check list. In 
post assessment the subjects were examined for pre-malignant changes 
in oral mucosa.  
3.15 PLAN FOR DATA ANALYSIS: 
Data analysis was planned to include descriptive and  inferential 
statistics. 
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Descriptive statistics: 
♣ Frequency and percentage distribution to analyse the demographic data 
for tobacco chewers 
♣ Mean, Mean percentage and standard deviation to assess the scores. 
Inferential statiststics: 
♣ Chi-square to associate between the selected demographic variables. 
3.16 ETHICAL CONSIDERATION 
The proposal of the study was approved by the experts prior to the 
pilot study by the ethics committee. Each individual subject was 
informed about the purpose of the study informed consent was obtained, 
assurance was given to them that confidentiality and privacy would be 
maintained. The subject was informed that he or she was having the 
freedom of leaving the study.  
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 29 
CHAPTER – IV 
“All great truths are simple in final analysis and easily understood; if 
they are not, they are not great truths”.  
- Napolean Hill 
ANALYSIS AND INTERPRETATION OF THE DATA 
This chapter explain the statistical analysis performed in the 
collected data. Analysis is a method for rending quantitative, meaningfu l 
and providing intelligible information, so that the research  problem can 
be studied and tested the relationship between the variables.  
Descriptive and inferential statistics were used for analyzing data 
in the light of the objectives of the study.  
The data analysis has been explained under following sections 
Section A: Demographic variables of samples. 
Section B: Medical related variables 
Section C: Pre and Post assessment of changes in oral mucosa before 
and after the application of Toludine Blue 
Section D: Association of demographic variables with premalignant 
changes in oral mucosa 
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SECTION A 
Table:1 Percentage Distribution Of Demographic Data (N=60) 
Demographic variables 
No. of tobacco 
Chewers 
% 
20 -30 yrs 10 16.7% 
31 -40 yrs 14 23.3% 
41 -50 yrs 20 33.3% 
Age 
51 -60 yrs 16 26.7% 
Male 35 58.3% Sex 
Female 25 41.7% 
Married 50 83.3% Marital status 
Widower 10 16.7% 
Hindu 49 81.7% 
Muslim 1 1.7% 
Religion 
Christian 10 16.7% 
Nuclear family 33 55.0% Type of family 
Joint family 27 45.0% 
Illiterate 9 15.0% 
Elementary 33 55.0% 
Higher secondary 16 26.7% 
Educational status 
Graduate 2 3.3% 
Private 26 43.3% 
Pensioner 8 13.3% 
Occupation 
Unemployed 26 43.3% 
< Rs.1000 47 78.3% 
Rs.1000 -2000 6 10.0% 
Income 
Rs.2000 -5000 7 11.7% 
Rural 31 51.7% Area of residence 
Urban 29 48.3% 
Vegetarian 12 20.0% 
Non vegetarian 3 5.0% 
Dietary pattern 
Mixed 45 75.0% 
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Demographic variables 
No. of tobacco 
Chewers 
% 
Yes 7 11.7% Familial history of 
cancer No 53 88.3% 
Father 4 57.1% 
Mother 1 14.3% If yes specify the 
relationship 
Brother 2 28.6% 
Previous 
knowledge  
regarding cancer 
Yes 
No 
43 
17 
67% 
33 
Mass media 10 16.7% 
Friends 12 20.0% 
Relatives 15 25.0% 
If yes, specify 
Health personnel 23 38.3% 
Table 1 shows the demographic information of tobacco chewers 
those who are participated in the study. It was seen that majority of the 
subjects are between 41-50 years of age and 58.3% are males and 81.7% 
are Hindus 83.3% are married and 55% are living in Nuclear family 33% 
are studied upto elementary education and 78.3% (47) their monthly 
income is less than Rs.1000/- 
75% (45) of them are taking mixed diet and 20% (12) of them are 
vegetarian 11.7% of them are having the family history of cancer. 67% 
(40) of them are aware of oral cancer and 33% (20) of them are not 
aware of cancer. But only 5% (3) of them are aware of the cancer 
screening measures.  
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Figure 3: Distribution of Age in percentage 
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Figure 4: Distribution of Gender in percentage 
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Figure 5: Distribution of Marital status in Percentage 
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Figure 6: Distribution of Religion in percentage 
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Figure 7:  distribution of subjects according to type of family system 
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Figure 8:  distribution of subjects according to Education status 
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Figure 9 .Distribution of the subjects according to Monthly Income 
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AREA OF RESIDENCE
Rural
51.7%
Urban
48.3%
 
Figure 10 .Distribution of the subjects according to Area of residence 
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FAMILY HISTORY OF CANCER
No
88.3%
Yes
11.7%
 
Figure 11 .Distribution of the subjects according to Family history of cancer 
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SECTION B 
Table 2: Medical Related Information     (N=60) 
 
No. of tobacco 
chewers 
% 
> 1 year 9 15.0% 
1-2  years 15 25.0% 
Tobacco chewing 
>2  years 36 60.0% 
Chewing 24 40.0% 
Pan-parag 25 41.7% 
Snuff 5 8.3% 
Manner of tobacco usage 
Kanja 6 10.0% 
3 times 19 31.7% 
3 -5 times 21 35.0% 
Tobacco usage per day 
> 5 times 20 33.3% 
Yes 33 55.0% Smoking 
No 27 45.0% 
4 -8 numbers 20 60.6% if yes,how many 
cigratte/beedi perday 
8 -10 numbers 13 39.4% 
Yes 28 46.7% Alcohol Intake 
No 32 53.3% 
This table 2 depicts that nearly 60% (36) subjects were having habit 
of tobacco chewing for more than 2 years and 25% (15) subjects were 
having 1-2 years and 15% (9) were more than one year of having habit of 
tobacco chewing.  
41.7% (25) subjects were using pan parag and 40% (24) subjects 
were chewing tobacco 35%(21) were using the tobacco for 3-5 times per 
day and 33.3% (20) were using more than 5 times per day. 
Associated factors like smoking is 55% (33) subjects were 
smoking and 60.6% (20) subjects were smoking 4-8 cigarretes per day. 
46.7% (28) subjects having the habit of taking alcohol along with 
tobacco chewing.  
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Figure 12 .Distribution of the subjects according to manner of tobacco use 
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SMOKING HABIT
Yes
55%
No
45%
 
Figure 13 .Distribution of the subjects according to Smoking habit 
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ALCOHOL HABIT
Yes
47%
No
53%
 
Figure 14 .Distribution of the subjects according to Alcohol habit
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Table 3: Observation tool for oral mucosal assessment  
 No. of tobacco chewer % 
Normal 100 100.0% 
Inflammed 0 0.0% 
Leukoplakia 0 0.0% 
Erythroplakia 0 0.0% 
Fibrosis 0 0.0% 
This table 3 describes about the appearance of oral mucosa. 100% 
of subjects were having normal mucosa while examining the oral 
mucosa.  
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Table 4: Assessment of Oral mucosa after application of toludine blue 
among tobacco chewers. 
 No. of tobacco chewer % 
Normal 30 50.0% 
Inflammed 10 16.7% 
Leukoplakia 13 21.7% 
Erythroplakia 7 11.7% 
Fibrosis 0 0.0% 
    Total 60 100.0% 
Table 4 shows the assessment of premalignant changes in oral 
mucosa after the application of toludine blue among tobacco chewers. 
50% of the tobacco chewers were having normal oral mucosa 16.7% of 
the tobacco chewers were having inflamed oral mucosa. 21.7% of them 
were having leukoplakia and 11.7% of them were having Erythroplakia.  
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Table 5: Comparison of the effectiveness of changes in oral mucosa 
before and after the application of toludine blue among tobacco 
chewers.  
Pre assessment Post assessment 
 
No. of 
tobacco 
chewer 
% 
No. of 
tobacco 
chewer 
% 
Chi square 
test 
Normal 100 100.0% 30 50.0% 
Inflammed 0 0.0% 10 16.7% 
Leukoplakia 0 0.0% 13 21.7% 
Erythroplakia 0 0.0% 7 11.7% 
Fibrosis 0 0.0% 0 0.0% 
χ2=61.54 
P=0.001*** 
DF=3 
    Total 100 100.0% 60 100.0%  
   Table 5 depicts that before application of toludine blue, all the 
tobacco chewer were having normal oral mucosa.  After application of 
toludine blue, only 50% are normal, 16.7% inflamed, 1.7% leukaplakia 
and 11.7% erythroplakia changes. 
This difference is statistically significant and it was calculated 
using chi square test. 
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Figure 15 .Distribution of the subjects according to pre-malignant changes in oral mucosa 
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Table 6: Difference between before and after assessment of 
premalignant changes in oral mucosa among tobacco chwers.  
 Normal 
Oral mucosa 
changes 
Percentage  Difference  with 
95% Confidence interval 
Pre- 
Assessment  
100% 0.0% 
Post- 
Assessment 
50% 50% 
50.0%(35.6% –64.3%) 
 
Table no 6 shows the difference between before and after assessment of 
pre malignant changes in oral mucosa among tobacco chewers. 
Toludine Blue Test identifies 50% of the cases( 30 out of 60) 
tobacco chewers were having changes in oral mucosa.  
Differences between pretest and posttest  score was analysed 
using proportion with 95% Confidence Interval . 
 50 
 
 
Figure 16 .Distribution of the subjects according to pre-assessment and post-assessment changes 
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Table 7: Association Between Demographic Variables And Pre-
Malignant Changes in Oral Mucosa 
TOLUDINE BLUE TEST ASSESSMENT 
Normal Inflammed Leukoplakia Erythroplakia 
 
 
n % n % n % n % 
Total Chi square test 
20 -30 yrs 8 80.0% 1 10.0% 1 10.0% 0 0.0% 10 
31 -40 yrs 9 64.2% 3 21.4% 2 14.3% 0 0.0% 14 
41 -50 yrs 9 45.0% 5 25.0% 3 15.0% 3 15.0% 20 
Age 
  
  
  
51 -60 yrs 4 25.0% 1 6.2% 7 43.7% 4 25.0% 16 
χ2=17.22 
P=0.04* 
Male 19 54.3% 2 5.7% 7 20.0% 7 20.0% 35 Sex 
  Female 11 44.0% 8 32.0% 6 24.0% 0 0.0% 25 
χ2=11.46 
P=0.01** 
Married 26 52.0% 9 18.0% 10 20.0% 5 10.0% 50 Marital 
status 
  
Widower 4 40.0% 1 10.0% 3 30.0% 2 20.0% 10 
χ2=1.65 
P=0.64 
Hindu 26 53.1% 6 12.2% 11 22.4% 6 12.2% 49 
Muslim     1 100.0%   1 
Religion 
  
  
Christian 4 40.0% 4 40.0% 1 10.0% 1 10.0% 10 
χ2=8.42 
P=0.20 
Nuclear 
family 15 45.5% 6 18.2% 7 21.2% 5 15.2% 33 
Type of 
family 
  Joint family 15 55.6% 4 14.8% 6 22.2% 2 7.4% 27 
χ2=1.17 
P=0.75 
Illiterate 5 55.6% 2 22.2% 2 22.2%   9 
Elementary 17 51.5% 3 9.1% 8 24.2% 5 15.2% 33 
Higher 
secondary 8 50.0% 4 25.0% 2 12.5% 2 12.5% 16 
Educational 
status 
  
  
  
Graduate   1 50.0% 1 50.0%   2 
χ2=7.47 
P=0.58 
Private 13 50.0% 4 15.4% 4 15.4% 5 19.2% 26 
Pensioner 4 50.0% 1 12.5% 3 37.5%   8 
Occupation 
  
  
Unemployed 13 50.0% 5 19.2% 6 23.1% 2 7.7% 26 
χ2=4.19 
P=0.65 
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TOLUDINE BLUE TEST ASSESSMENT 
Normal Inflammed Leukoplakia Erythroplakia 
 
 
n % n % n % n % 
Total Chi square test 
< Rs.1000 22 46.8% 9 19.1% 11 23.4% 5 10.6% 47 
Rs.1000 -
2000 3 50.0% 1 16.7% 0 0.0% 2 33.3% 6 
Income 
  
  
Rs.2000 -
5000 5 71.4% 0 0.0% 2 28.6% 0 0.0% 7 
χ2=6.87P=0.33 
Rural 15 48.4% 4 12.9% 9 29.0% 3 9.7% 31 Area of 
residence 
  
Urban 15 51.7% 6 20.7% 4 13.8% 4 13.8% 29 
χ2=2.40 
P=0.49 
Vegetarian 4 33.3% 3 25.0% 4 33.3% 1 8.3% 12 
Non 
vegetarian 2 66.7% 0 0.0% 1 33.3% 0 0.0% 3 
Dietary 
pattern 
  
  
Mixed 24 53.3% 7 15.6% 8 17.8% 6 13.3% 45 
χ2=3.75 
P=0.70 
* significant at P≤0.05  ** highly significant at P≤0.01  *** very high significant at   P≤0.001   
Table 7 shows the association between the pre- malignant lesion 
and their demographic variables had less education and less income, 
elders and males were having more changes than others. statistical 
significance was calculated using chi square test. 
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Figure 17: shows Association between Age and Pre-Malignant changes 
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Figure 18: shows Association Between Sex And Pre- Malignant Changes
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Table 8: Association between cancer related variables and malignant 
changes in oral mucosa 
TOLUDINE BLUE TEST ASSESSMENT 
Normal Inflammed Leukoplakia Erythroplakia 
 
  
n % n % n % n % 
Total 
Chi  
square 
test  
Yes 5 71.4% 0 0.0% 2 28.6% 0 0.0% 7 Familial 
history of 
cancer No 25 47.2% 10 18.9% 11 20.8% 7 13.2% 53 
χ2=3.14 
P=0.36 
Father 2 50.0% 0 0.0% 2 50.0% 0 0.0% 4 
Mother 1 100.0% 0 0.0% 0 0.0% 0 0.0% 1 
If yes 
specify the 
relationship  
Brother 2 100.0% 0 0.0% 0 0.0% 0 0.0% 2 
χ2=2.10 
P=0.35 
Previous 
knowledge 
regarding 
cancer 
Yes 
30 50.0% 10 16.7% 13 21.7% 7 11.7% 60 χ2=0.00 P=1.00 
Mass 
media 7 70.0% 2 20.0% 0 0.0% 1 10.0% 10 
Friends 6 50.0% 1 8.3% 4 33.3% 1 8.3% 12 
Relatives 10 66.7%   5 33.3% 0 0.0% 15 
If yes, 
specify  
Health 
care 
personnel 
7 30.4% 7 30.4% 4 17.4% 5 21.7% 23 
χ2=7.02 
P=0.15 
Table 8 shows the association between cancer related  variables 
and pre-malignant changes in oral mucosa. None of the variables are 
associated. Statistical significance was calculated using chi square test. 
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Table 9: Association Between Tobacco Related Variables And Pre-
Malignant Changes in Oral Mucosa 
TOLUDINE BLUE TEST ASSESSMENT 
Normal Inflammed Leukoplakia Erythroplakia 
 
 
n % n % n % n % 
Total 
Chi  
square  
test 
< 1 year 0  0.0%  0  0.0%  3 33.3% 6 66.7% 9 
1-2  
years 14 93.3% 0  0.0%  0  0.0%  1 6.7% 15 
Tobacco  
chewing 
>2  
years 16 44.4% 10 27.8% 10 27.8% 0  0.0%  36 
χ2=8.31 
P=0.14 
Chewing 14 58.3% 0  0.0%  3 12.5% 7 29.2% 24 
Pan 13 52.0% 2 8.0% 10 40.0% 0  0.0%  25 
Snuff 3 60.0% 2 40.0% 0  0.0%  0  0.0%  5 
Manner of  
tobacco 
usage  
Kanja 
0  0.0% 6 100.0% 0  0.0% 0 0.0% 6 
χ2=52.90 
P=0.001*** 
3 times 11 57.9% 0  0.0%  8 42.1% 0  0.0%  19 
3 -5 
times 5 23.8% 10 47.6% 5 23.8% 1 4.8% 21 
Tobacco 
usage  per 
day 
> 5 
times 14 70.0% 0  0.0%  0  0.0%  6 30.0% 20 
χ2=40.16 
P=0.001*** 
Yes 10 30.3% 7 21.2% 12 36.3% 4 12.1% 33 Smoking  
No 20 74.1% 3  11.1%  1 3.7% 3 11.1% 27 
χ2=13.9 
P=0.03* 
4 -8 
numbers 6 30.0% 8 40.0% 6 30.0% 0  0.0%  20 
if yes,how 
many 
cigratte/beedi 
perday 
8 -10 
numbers 4 30.8% 2 15.4% 5 38.5% 2 15.4% 13 
χ2=4.82 
P=0.18 
Yes 18 64.3% 0  0.0%  3 10.7% 7 25.0% 28 Alcohol 
Intake  No 12 37.5% 10 31.3% 10 31.3% 0  0.0%  32 
χ2=21.79 
P=0.001*** 
* significant at P≤0.05  ** highly significant at P≤0.01  *** very high significant at   P≤0.001   
Table 9 shows the association between Tobacco related variables 
and pre-malignant changes in oral mucosa. Chewers, more time tobacco 
chewers, smokers and alcoholic persons were having more changes than 
others. Statistical significance was calculated using chi square test. 
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Figure 19: shows Association between Manner of Tobacco usage and pre- malignant changes 
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Figure 20: shows Association between perday Tobacco usage and pre-malignant changes 
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Figure 21: shows Association between smoking habit and pre-malignant changes 
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Figure 22: shows Association between Alcohol habit and pre- malignant changes 
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CHAPTER – V 
 DISCUSSION 
“Discussion is an exchange of knowledge, arugment is an exchange of 
ignorance”  
Robert Quillen 
This study was conducted to identify the pre-malignant changes in 
oral mucosa among tobacco chewers by toludine blue test at medical 
wards at RGGGH, Chennai. The discussion of the study findings are 
presented in this chapter.  
The discussion is based on the objects specified in the study  
OBJECTIVES 
1. To identify the changes in oral mucosa among tobacco chewers 
2. To assess the oral mucosa after application of toludine blue 
among tobacco chewers. 
3. To compare the effectiveness of changes in oral mucosa before 
and after the application of toludine blue among tobacco 
chewers.  
4. To find out the association between the selected demographic 
variables and the effectiveness of toludine blue among tobacco 
chewers.  
Review of literature facilitated the investigator to collect relevant 
information to support the study to design the methodology and to 
develop tools.  
The sample size 60 people who were admitted in medical wards at 
RGGGH, Chennai. The cross sectional descriptive analysis.  
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CHARACTERISTICS OF DEMOGRAPHIC VARIABLES  
Demographic information of tobacco chewers those who are 
participated in the study. It was seen that majority of the subjects are 
between 41-50 years of age and 58.3% are males and 81.7% are Hindus 
83.3% are married and 55% are living in Nuclear family 33% are studied 
upto elementary education and 78.3% (47) their monthly income is less 
than Rs.1000/- 
75% (45) of them are taking mixed diet and 20% (12) of them are 
vegetarian 11.7% of them are having the family history of cancer. 67% 
(40) of them are aware of oral cancer and 33% (20) of them are not 
aware of cancer. But only 5% (3) of them are aware of the cancer 
screening measures.  
CHARACTERISTICS OF MEDICAL RELATED VARIABLES  
Depicts that nearly 60% (36) subjects were having habit of tobacco 
chewing for more than 2 years and 25% (15) subjects were having 1-2 years 
and 15% (9) were more than one year of having habit of tobacco chewing.  
41.7% (25) subjects were using pan parag and 40% (24) subjects 
were chewing tobacco 35%(21) were using the tobacco for 3-5 times per 
day and 33.3% (20) were using more than 5 times per day. 
Associated factors like smoking is 55% (33) subjects were 
smoking and 60.6% (20) subjects were smoking 4-8 cigarretes per day. 
46.7% (28) subjects having the habit of taking alcohol along with 
tobacco chewing.  
The first objective is to identify the changes in oral mucosa among 
tobacco chewers.  
The factors identified for the occurrence of Pre-malignant changes 
were demographic data, personal habits like tobacco chewing, pan 
parag, alcohol usage and smoking 67% of them had previous knowledge 
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regarding oral cancer and 33% of them were not aware of the oral 
cancer.  
The demographic data analysis showed that most of the 
respondents were 41-50 years 33.3%, most of them were males 58.3%. 
Regarding the marital status most of them were married 83.3% living 
with there spouse and 55% of them were having urban family statistical 
significance was calculated by using chisquare test. Regarding religion 
majority of them who Hindu 81.7%, 1.7% Muslim and 16.7% were 
Christian.  
Regarding the educational status 55% of them were finished 
elementary education and their occupationwas private 43.3% and 
unemployed was 43.3% and their monthly income was less than Rs.1000 
was 78.3% most of the 51.7% were living in rural area and 48.3% were 
living in urban and they are taking mixed type of diet 75%.  
Regarding the familiar history of cancer 88.3% was not having 
familial history and 11.7% are having family history of cancer and it 
was close relationship like father is 57.1% and brother was 28.6% and 
mother was 14.3% on the analysis of previous knowledge regarding 
cancer 67% of them who having some knowledge and 33% of them were 
not aware of cancer and most of them 38.3% were known about cancer 
by health care personnel.  
Regarding the medical related information 60% of the people 
were having habit of tobacco chewing more than 2 years and 41.7% 
were using pan parag and 40% were having habit of chewing tobacco 
and 8.3% were using snuff and the tobacco usage per day is more than 
3-5 times .35% were associated with smoking iand 55% were yes and 
45% were not  having  habit of smoking. 60.6% were using 4-8 
cigarettes/ day and regarding alcohol intake it was 46.7% and not using  
alcohol was 53.3%.  
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The clinical assessment in the pretest among premalignant 
changes in oral mucosa among tobacco chewers shows 100% of the 
tobacco chewers oral mucosa appears normal.  
 The second objective is to assess the oral mucosa after application of 
toludine blue among tobacco chewers.  
Screening of the people the assessment of pre malignant changes 
in oral mucosa after application of toludine blue among tobacco chewers 
were having normal oral mucosa and 16.7% were having inflamed oral 
mucosa and 21.7% were having leukoplakia and 11.7% are having 
erythroplakia for the visual examination of the oral mucosa after the 
application of 1% toludine blue and 1% acetic acid by using aided 
magnification.  
The third objective is to compare the effectiveness of changes in oral 
mucosa before and after the application of toludine blue among 
tobacco chewers.  
Comparison of the effectiveness of changes in oral mucosa shows 
before the application of toludine blue all the tobacco chewers 100% 
were having normal oral mucosa. After the application of toludine blue 
only 50% were normal  and 16.7% were inflamed, 1.7% has leukoplakia 
and 11.7% were having erythroplakia changes. This difference is 
statistically significant and it was calculated using chi-square test.   
Difference between pretest and post test score was analysed using 
proportion with 95% confidence interval.  
To find out the association between the selected demographic variables 
and the effectiveness of toludine blue among tobacco chewers.  
This study shows that there was an association between 
demographic variables and pre-malignant changes in oral mucosa. 
Elders and males were having more changes than others. statistical 
significance was calculated using chi square test.  
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There was an association between pre-malignant changes in oral 
mucosa and their personal habits. Habit of using tobacco by chewing 
and smoking. Statistical significance was calculated using chi square 
test.  
This study shows the association between pre-malignant lesion 
and their age and gender. Elders and males were mostly affected than 
others. Statistical significance was calculated using chi-square test.  
According to the chi-square test there was no association between 
cancer related variables and pre-malignant changes in oral mucosa.   
Tobacco related variables and pre-malignant changes in oral 
mucosa   more time tobacco chewers, smokers and alcoholic persons 
were having m ore changes than others. statistical significance was 
calculated by chi-square test.  
Regarding before application of toludine blue,  visual  
examination of oral mucosa by magnifying lens, all the tobacco chewers 
were having normal oral mucosa. After application of 1% toludine blue, 
followed by 1% acetic acid, followed by 1% toludine blue. This 
difference was statistically significant and it was calculated using Chi 
square test and difference between pretest and post test score was 
analysed using proportion with 95% confidence interval and guidance 
45%.  
Warna kula suriya et. al., (2011) had conducted a study to 
determine cancer awareness among people of low-socio economic status 
in Mumbai slums. The study concluded that oral cancer creating 
awareness about screening its availability and motivating the general 
population for screening is necessary.  
 66 
CHAPTER – VI 
SUMMARY, RECOMMENDATION AND IMPLICATION 
6.1 SUMMARY 
A cross sectional descriptive study was conducted to identify the 
factors associated with occurrence of pre-malignant changes in the oral 
mucosa among tobacco chewers by the visual inspection by the 
application of 1% Toludine blue and 1% acetic acid. This study was 
based on Roy Adoptation Model  
60 people were selected by convenient sampling technique and 
data were collected by using structured questionnaire. Descriptive and 
inferential statistics were used in data analysis.  
The finding of the study includes the usage of tobacco chewers by 
the respondents. The factors identified and associated with demographic 
variables were age, gender, tobacco usage, chewing, snuff, smoking 
alcohol usage.  
The characteristic of oral mucosa were identified by visual 
examination and it appeared normal in pre test for all the participants.  
6.2 MAJOR FINDINGS OF THE STUDY  
• Majority of the people were between 41-50 years of age and 
58.3% of them more 81.7 of them were Hindus, 83.3% of them 
were married and 55% of them were living as a nuclear family.  
• 55% of them have studied up to elementary education and 43% 
were working in private and 43% were  unemployed of them 
are earning about < Rs.1000 per month are 78.3% and 51.7% 
were living in rural area and 75% of them are taking mixed 
type of diet.  
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• 11.7% of them are having the family history of cancer and 
57.1% of fathers  having family history of cancer 67% of them 
are aware of oral cancer and 33% of them have not aware of 
cancer. But only 3% of them having aware of the oral cancer 
screening measures.  
• 60% of them are having habit of tobacco chewing for more 
than 2 years and 41.7% are using pan parag usage 35% of them 
were using tobacco usage per day is 3-5 times.  
• 55% of them were having habit of smoking, 60.6% of them 
were smoking 4-8 numbers of cigarette per day and 39.4% of 
them were using 8-10 cigarettes per day, 46. 7% of them were 
taking alcohol while using tobacco.  
• There is no association between the cancer related and pre-
malignant changes in oral mucosa 
• 50% of the people had positive for pre malignant changes in 
oral mucosa after application of 1% toludine blue and 1% 
acetic acid and 1% toludine blue and 50% of the people were 
negative for the visual examination of the oral mucosa after the 
application of 1% toludine blue and 1% acetic acid and 1% 
toludine blue by using aided magnification.  
6.3 NURSING IMPLICATIONS 
The study has implication for nursing practice, education, 
administration and research.  
NURSING PRACTICE  
• The nurse has a vital role in providing information for all 
people who are using tobacco.  
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• Awareness programmes regarding cancer screening 
programmes available at all health care centre including 
primary health centre.  
• The nurse has to educated the people regarding the risk factors 
while using tobacco and to educate about screening programme 
and preventive measures.  
• The study will be helpful for the nurse to educate the people 
regarding the treatment facilities available for the pre-
malignant lesion. 
NURSING EDUCATION  
• In nursing curriculum general information about the cancer 
screening programmes.  
• Nursing curriculum should emphasis on health education and 
counseling the people regarding the oral cancer screening  
• Hence a holistic approach may be considered and reinforced 
among the people with regard to prevention of oral cancer  
NURSING ADMINISTRATION 
• All health care set up, primary health centres and sub-centres – 
nursing personal should be utilized for oral cancer screening 
programme.  
• Mass media education on cancer screening should be broad 
casted regularly  
• Community participation can be enhanced by utilizing self 
help group and other social welfare organization.  
• Non governmental organization.  
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NURSING RESEARCH  
• Nurses can be motivated to participate in counseling session 
for the people who are under going cancer screening  
• The opportunities can be provided to the nurses to update the 
knowledge about cancer screening programme.  
6.4 RECOMMENDATIONS FOR FURTHER STUDY  
1. An awareness programme can be conducted in all institution 
and primary health centres regarding pre-malignant changes 
and the screening methods.  
2. A study can be conducted to assess the stress level among 
people who are undergoing  screening method. 
3. The same study can be conducted on a large sample.  
4. Mass health education programme to be given among people 
who are using tobacco in any manner, who are vulnerable to 
pre-malignant lesion.  
5. A comparative study should be conducted with rural and urban 
population.  
6. A study to assess the attitude of the people towards the oral 
cancer screening programme.  
6.5 CONCLUSION 
Oral health is essential in improving one’s quality of life. Factors 
that influence the development of oral cancer include tobacco usage. 
oral cancer is preventable in an early stage. As the disease progresses 
the disability and quality of life deteriorate. Toludine blue test is a  
simple therapeutic modality which can be carried out in the primary 
health centre and is economical to identify pre-malignant changes. The 
present study shows that toludine blue test is more effective to identify 
pre-malignant changes in oral mucosa.   
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TOOL FOR THE STUDY: 
 
PART  -  A  : DEMOGRAPHIC PROFILE 
 
Sample no: 
 
1.  Age of the person       
a) 18 - 30 years  b) 31-40 years c) 41 - 50 years     
d)51- 60 years 
 
2. Sex  
a). Male                    b). Female   
    
3. Marital status 
a) Married  b) Unmarried                   c) Divorced / Separated  
d) Widower/widow 
4. Religion   
     a) Hindu          b) Muslim       c) Christian            
d) Others                                
5. Type of family               
    a) Nuclear      b) Joint c) Broken             d) Paying guest 
 
6. Educational status         
     a) Illiterate   b) Elementary     c) Higher secondary        
    d) Graduate and above    
 
7. Occupation 
a) Government                  b) Private              
c) Pensioner                d) Unemployed   
 
8.  Income  
a) <Rs 1000 / month                  b) Rs 1000- 2000 / month        
c) Rs 2000- 5000 / month                d) >Rs 5000 /month      
 
9. Area of residence 
     a) Rural                           b) Urban    
 
10. Dietary pattern 
     a)  Vegetarian      b) Non- vegetarian          c) Mixed 
 11.Familial  History of cancer 
a) yes                         b) No   
12. If yes, specify the relationship 
 
a) Father                b)Mother            c)Brother              d)Sister  
13.  previous  knowledge regarding cancer 
 
a) Yes                      b)No 
14. If  yes, specify  
 
a)Mass media      b)Friends          c)Relatives       
d)Healthpersonnel 
PART   -  B  :  MEDICAL RELATED INFORMATION 
FACTORS ASSOCIATED WITH PRE-MALIGNANT CHANGES IN 
ORAL  MUCOSA  _DETAILS OF  TOBACCO USAGE 
1.Tobacco chewing 
<1year                     >1year              1-2years               >2years 
2.Manner of tobacco usage 
      Chewing     Pan-parag          Snuff              Kanja 
3. Tobacco usage per day 
      3times          3-5times            >5times 
4.Smoking 
      Yes            No                                     
5.If  yes, how many beedi/cigareete per day 
 4-8 numbers         8-10 numbers        10-20 numbers           3packet and above  
6.Alcohol intake 
Yes                      No 
CHECK LIST TO ASSESS THE WOUND HEALING PROCESS 
 
S.No Item Assessment Score  Day 
1 
Day 
5 
Day 
10 
Day 
15 
1.  Size  • Length X width < 4 sq cm 
• Length X width < 4 - 16 sq cm 
• Length X width < 16.1 - 36 sq cm 
3 
2 
1 
   
2.  Depth • Tissues damaged but no break in skin surface.  
• Superficial, abrasion, blister or shallow crater. Even with, &/or elevated 
above skin surface (e.g., hyperplasia).  
• Deep crater with or without undermining of adjacent tissue.  
3 
2 
 
1 
   
3.  Edges  • Not attached sides or walls are present; floor or base of wound is deeper than 
edge.  
• Rolled under, thickened soft to firm and flexible to touch. Indistinct, diffuse 
unable to clearly distinguish wound outline.  
• Attached even or flush with wound 
• Hyperkeratosis callous-like tissue formation around wound & at edges.  
• Fibrotic, scarredhard, rigid to touch.  
5 
 
4 
 
3 
2 
 
1 
   
4.  Undermining • Undermining < 2 cm in any area. 
• Undermining 2-4 cm involving <50% wound margin. 
• Undermining 2-4 cm involving >50% wound margin. 
• Undermining >4 cm in any area. 
• Tunneling and or sinus tract formation. 
5 
4 
3 
     2 
1 
 
   
S.No Item Assessment Score  Day 
1 
Day 
5 
Day 
10 
Day 
15 
5.  Necrotic 
tissue type 
• Non visible. 
• White / grey non – viable tissue and or non adherent yellow slough. 
• Loosely adherent yellow slough. 
• Adherent, soft, black eschar. 
• Firmly adherent, hard, black eschar. 
5 
4 
3 
2 
1 
 
 
 
 
 
   
6.  Necrotic 
tissue amount 
• Non visible. 
• < 25% of wound bed covered. 
• 25%  to 50% of wound covered. 
• > 50% and < 75% of wound covered. 
• 75% to 100% of wound covered. 
5 
4 
3 
2 
1 
    
7.  Exudate type • None or bloody. 
• Serous:  thin, watery, clear. 
• Purulent:  thin or thick, opaque, tan/yellow. 
• Foul Purulent: Thick, opaque, yellow/green with odour. 
4 
3 
2 
1 
    
8.  Exudate 
amount 
• None 
• Scanty 
• Small 
• Moderate 
• Large 
5 
4 
3 
2 
1 
 
 
 
 
 
   
9.  Skin colour 
surrounding 
the wound 
• Pink or normal 
• Bright red and or blanches to touch. 
• White or grey pallor or hypo pigmented 
• Dark red or purple and or non blanchable 
6 
5 
4 
3 
   
S.No Item Assessment Score  Day 
1 
Day 
5 
Day 
10 
Day 
15 
9. 
 • Dark red blanchable  
• Black or hyper pigmented. 
2 
1 
    
10. Peripheral 
tissue edema 
• Minimal swelling around wound. 
• Non pitting oedemaextends< 4cm around wound. 
• Non pitting oedema extends  > 4cm around wound 
• Pitting oedema extends < 4cm around wound. 
• Crepitus and or pitting edema extends  > 4cm 
5 
4 
3 
2 
1 
    
11. Peripheral 
tissue 
induration 
• Minimal firmness around the wound. 
• Induration < 2cm around the wound. 
• Induration 2 – 4 cm extending < 50% around the wound. 
• Induration 2 – 4 cm extending >50% around the wound. 
• Induration  > 4cm in any area. 
5 
4 
3 
2 
1 
   
12. Granulation 
tissue 
• Skin intact or partial thickness wound. 
• Bright, beefy red; < 75% and > 25% of wound filled. 
• Pink, and or dull, dusky red and or fills < 25% of wound. 
• No granulation tissue present. 
4 
3 
2 
1 
   
13. Epithelialisati
on 
• 100% wound covered, surface intact. 
• 75% to 100% wound covered.  
• 50% to 75% wound covered.   
• 25% to 50% wound covered. 
• <25% wound covered. 
5 
4 
3 
2 
1 
   
 
SCORE 
    60    
INTERPRETATION: 
 
S. NO. SCORE RESULT 
1.  50   to  60 Very good 
2.  40  to  49 Good 
3.  30  to  39 Moderate 
4.  20  to  29 Mild 
5.  <  19 Poor 
 
 1 
brÉÈa® fšÿÇ, br‹id kU¤Jt¡ fšÿÇ 
rKjha ne®fhzš got« 
gFâ-m 
Ra Étu nfŸÉ¤jhŸ 
khâÇ v©.:  
1) taJ 
m)  18-30 taJ  
M) 31-40 taJ  
ï) 41- 50 taJ  
<) 51- 60 taJ  
2) ghÈd« 
m)  M©  
M) bg©  
3) âUkz Égu« 
m)  âUkz« Mdt®  
M) âUkz« Mfhjt®  
ï) Éthfu¤jhdt®  
<) Jizia ïHªjt®   
4) rka« 
m)  ïªJ  
M) »¿ÞJt®  
ï) KÞÈ«  
<) k‰wt®  
5) FL«gtif 
m)  jÅ¡FL«g«  
M) T£L¡FL«g«  
ï) ãÇªjFL«g«  
<) k‰wtif  
 2 
6) fšÉ¤jFâ 
m)  go¡fhjt®  
M) Mu«g¡ fšÉ  
ï) ca®fšÉ  
<) fšÿÇ go¥ò  
7) bjhÊš Égu« 
m)  muR ÃWtd«  
M) jÅah® ÃWtd«  
ï) XŒñâa« bgWgt®  
<) ntiy ïšyhjt®  
8) khj tUkhd« 
m)  %.1000¡FŸ  
M) %.1000- %.2000  
ï) %.2000- %.5000  
<) %.5000¡F nkš  
9) thœÉl« 
m)  efu¥gFâ  
M) »uhk¥gFâ  
10) czî gH¡ftH¡f« 
m)  irt«  
M) mirt«  
ï) ïu©L«  
11) FL«g¤âš ahuhtJ ò‰W nehahš ghâ¡f¥g£LŸsh®fsh? 
m)  M«  
M) ïšiy  
12) M« vÅš cwîKiw 
m)  jªij  
M) jhŒ  
ï) rnfhju®   
<) rnfhjÇ  
 3 
13) ïj‰FK‹ ò‰WnehŒ g‰¿a Égu« bjÇíkh  
m)  M«  
M) ïšiy  
14) M« vÅš F¿¥ãlî« 
m)  jftš bjhÊšE£g«  
M) e©g®fŸ  
ï) cwÉd®fŸ  
<) kU¤Jt CÊa®fŸ  
 
 
 4 
gFâ-M 
kU¤Jt« rh®ªj jftš 
1) òifÆiy bkšY« gH¡f« 
m)  1 tUl¤â‰F« Fiwî  
M) 1 tUl¤â‰F« nkš  
ï) 1-2 tUl«  
<) 2 tUl¤â‰F nkš  
2) òifÆiy cgnah»¡F« Kiw 
m)  òifÆiy bkšYjš  
M) gh‹guh¡  
ï) bgho nghLjš  
<) fŠrh  
3) xU ehis¡F òifÆiy v¤jid Kiw cgnah»¡»Ö®fŸ 
m)  _‹W Kiw  
M) 3-5 Kiw  
ï) 5 Kiw¡F nkš  
4) òifão¡F« gH¡f« cŸsjh 
m)  M«  
M) ïšiy  
5) M« vÅš xU ehis¡F v¤jid Õo/á»bu£ ão¡»Ö®fŸ 
m)  4 Kjš 8 tiu  
M) 8 Kjš 10 tiu  
ï) 10 Kjš 20 tiu  
<) 3 gh¡bf£L¡F nkš  
6) kJ¥gH¡f« cŸsjh 
m)  M«  
M) ïšiy  
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